Skip to content

Exercise Trial in Chronic Kidney Disease

Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01462097
Acronym
AWARD
Enrollment
99
Registered
2011-10-28
Start date
2012-03-31
Completion date
2017-10-31
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Chronic kidney disease, Exercise, Aerobic capacity, Learning and memory, Executive function, Endothelial function

Brief summary

Chronic Kidney Disease (CKD) is exceedingly common in older adults, in whom it is associated with impairment in cognition and physical function. The purpose of this study is to test the effects of 12 months of aerobic and resistance exercise training compared to health education on cognitive and physical performance in 120 older adults with CKD not requiring dialysis. The results of this study will be essential for demonstrating the effectiveness of exercise in improving function and ultimately preventing disability in this high-risk population of older adults.

Detailed description

This is a parallel-group randomized controlled trial comparing 12 months of aerobic and resistance exercise training vs. health education (attention control) on neurocognitive and physical performance among community-dwelling older adults (age \>55) and CKD stage 3b and 4. Co-primary outcomes are change in physical performance (including aerobic capacity and submaximal walking) and neurocogntive performance (including executive functions). Outcome measures will be assessed at baseline and after 6- and 12 months. Exercise training will occur thrice weekly at a dedicated research exercise center and will be supervised by exercise specialists.

Interventions

BEHAVIORALAerobic exercise training

12 months of aerobic exercise

BEHAVIORALHealth Education

12 months of health education sessions

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Stage 3-4 Chronic kidney disease (estimated Glomerular Filtration Rate 15-45) * Age 60 to 85 * English Speaking

Exclusion criteria

* Dementia or cognitive impairment * Renal transplant * New York Heart Association class 3-4 heart failure * Severe Chronic Lung Disease * Unstable angina or coronary revascularization within the last 3 months * Orthopedic problems that would preclude aerobic exercise training * Known, untreated infection * Disabling arthritis * Uncontrolled arrhythmia * More than 14 alcoholic drinks per week

Design outcomes

Primary

MeasureTime frameDescription
Change in Peak Aerobic CapacityBaseline, 6 months, 12 monthsVO2peak, measured by Graded Exercise Treadmill Test (GXT) with a modified Balke protocol - higher indicates better aerobic capacity
Change in 6 Minute WalkBaseline, 6 months, 12 monthsDistance walked in 6 minutes - greater distance represents higher function

Secondary

MeasureTime frameDescription
Change in Physical FunctionBaseline, 6 months, 12 monthsTimed Up and Go Test
Number With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)Baseline, 6 months, 12 monthsShort Physical Performance Battery is a test of lower extremity function designed to be administered in older adults, consisting of three components: 1) usual gait speed over a 4-meter course; 2) five repeated chair stands; 3) standing balance battery. Each component is scored 0-4, with higher scores indicating better function, and the total scores of each component are summed (range, 0-12).

Countries

United States

Participant flow

Recruitment details

March 2012 through June 2016 recruited from the University of Maryland Medical Center, VA Maryland Healthcare System, Tufts Medical Center, and Partners Healthcare.

Participants by arm

ArmCount
Aerobic Exercise
12 months of treadmill walking and strength training exercise. Exercise is gradually progressed in walking speed and time on the treadmill based on the individual's tolerance, abilities, and safety. For months 1-6 exercise will take place 3 times per week at the research center. For months 6-12 exercise will take place 2 times per week at the center and 1 time per week at home. Aerobic exercise training: 12 months of aerobic exercise
49
Health Education
12 months of Health education sessions which will cover topics important to older adults (safe travel, age-appropriate preventative screenings, resources for reliable health information, and topics relevant to chronic kidney disease). For months 1-6 classes will take place 1 time per week. For months 6-12 classes will take place 1 time per month. Health Education: 12 months of health education sessions
50
Total99

Baseline characteristics

CharacteristicAerobic ExerciseHealth EducationTotal
Age, Continuous67.9 years
STANDARD_DEVIATION 7.7
68.1 years
STANDARD_DEVIATION 8.8
68.0 years
STANDARD_DEVIATION 8.2
Body Mass Index (kg/m2)30.3 kg/m2
STANDARD_DEVIATION 7.2
31.8 kg/m2
STANDARD_DEVIATION 5.8
31.1 kg/m2
STANDARD_DEVIATION 6.5
Chronic Obstructive Pulmonary Disease (COPD)5 Participants8 Participants13 Participants
Coronary Artery Disease16 Participants13 Participants29 Participants
Diabetes30 Participants28 Participants58 Participants
Estimated glomerular filtration rate (eGFR)34.1 ml/min/1.73m^2
STANDARD_DEVIATION 9.5
32.6 ml/min/1.73m^2
STANDARD_DEVIATION 11.4
33.3 ml/min/1.73m^2
STANDARD_DEVIATION 10.5
Heart Failure6 Participants4 Participants10 Participants
Hemoglobin (g/dl)12.5 g/dL
STANDARD_DEVIATION 1.6
12.3 g/dL
STANDARD_DEVIATION 1.7
12.4 g/dL
STANDARD_DEVIATION 1.6
Hypertension44 Participants48 Participants92 Participants
Peripheral vascular disease3 Participants6 Participants9 Participants
Race/Ethnicity, Customized
African-American
27 Participants34 Participants61 Participants
Race/Ethnicity, Customized
Caucasian
18 Participants13 Participants31 Participants
Race/Ethnicity, Customized
Other
4 Participants3 Participants7 Participants
Region of Enrollment
United States
49 participants50 participants99 participants
Self-reported Moderate-vigorous physical activity72 minutes/week
STANDARD_DEVIATION 126
90 minutes/week
STANDARD_DEVIATION 174
78 minutes/week
STANDARD_DEVIATION 150
Sex: Female, Male
Female
15 Participants10 Participants25 Participants
Sex: Female, Male
Male
34 Participants40 Participants74 Participants
Study Site
Tufts
21 Participants22 Participants43 Participants
Study Site
Univ Maryland
28 Participants28 Participants56 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 492 / 50
other
Total, other adverse events
30 / 4931 / 50
serious
Total, serious adverse events
21 / 4934 / 50

Outcome results

Primary

Change in 6 Minute Walk

Distance walked in 6 minutes - greater distance represents higher function

Time frame: Baseline, 6 months, 12 months

Population: Total # with at least one measurement

ArmMeasureGroupValue (MEAN)Dispersion
Aerobic ExerciseChange in 6 Minute WalkBaseline1298 FeetStandard Deviation 323
Aerobic ExerciseChange in 6 Minute Walk6 months1649 FeetStandard Deviation 620
Aerobic ExerciseChange in 6 Minute Walk12 months1453 FeetStandard Deviation 368
Health EducationChange in 6 Minute WalkBaseline1251 FeetStandard Deviation 394
Health EducationChange in 6 Minute Walk6 months1247 FeetStandard Deviation 454
Health EducationChange in 6 Minute Walk12 months1284 FeetStandard Deviation 462
Primary

Change in Peak Aerobic Capacity

VO2peak, measured by Graded Exercise Treadmill Test (GXT) with a modified Balke protocol - higher indicates better aerobic capacity

Time frame: Baseline, 6 months, 12 months

Population: Participants with complete V02peak at \>=1 time point

ArmMeasureGroupValue (MEAN)Dispersion
Aerobic ExerciseChange in Peak Aerobic CapacityBaseline17.1 ml/kg/minStandard Deviation 5.3
Aerobic ExerciseChange in Peak Aerobic Capacity6 months17.9 ml/kg/minStandard Deviation 5.5
Aerobic ExerciseChange in Peak Aerobic Capacity12 Months18.7 ml/kg/minStandard Deviation 5.2
Health EducationChange in Peak Aerobic CapacityBaseline16.8 ml/kg/minStandard Deviation 5.6
Health EducationChange in Peak Aerobic Capacity6 months15.9 ml/kg/minStandard Deviation 7
Health EducationChange in Peak Aerobic Capacity12 Months17.2 ml/kg/minStandard Deviation 6.4
Secondary

Change in Physical Function

Timed Up and Go Test

Time frame: Baseline, 6 months, 12 months

Population: \# of participants with complete measures

ArmMeasureGroupValue (MEAN)Dispersion
Aerobic ExerciseChange in Physical FunctionBaseline8.2 SecondsStandard Deviation 2.4
Aerobic ExerciseChange in Physical Function6 months8.0 SecondsStandard Deviation 2.6
Aerobic ExerciseChange in Physical Function12 months8.3 SecondsStandard Deviation 29
Health EducationChange in Physical FunctionBaseline8.6 SecondsStandard Deviation 2.7
Health EducationChange in Physical Function6 months9.3 SecondsStandard Deviation 3.6
Health EducationChange in Physical Function12 months9.0 SecondsStandard Deviation 2.9
Secondary

Number With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)

Short Physical Performance Battery is a test of lower extremity function designed to be administered in older adults, consisting of three components: 1) usual gait speed over a 4-meter course; 2) five repeated chair stands; 3) standing balance battery. Each component is scored 0-4, with higher scores indicating better function, and the total scores of each component are summed (range, 0-12).

Time frame: Baseline, 6 months, 12 months

Population: \# of participants with complete measures

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Aerobic ExerciseNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)Baseline19 Participants
Aerobic ExerciseNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)6 months9 Participants
Aerobic ExerciseNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)12 months9 Participants
Health EducationNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)Baseline19 Participants
Health EducationNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)6 months15 Participants
Health EducationNumber With Short Physical Performance Battery (SPPB) Score <10 (Out of 12 Maximum)12 months16 Participants

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026